Saundra Pelletier

Bio:

Ms. Pelletier is an expert in women’s health, with insight driven by both intensive consumer research and deep commercial experience in the global markets with products addressing women’s health spanning every stage in their reproductive journey, from puberty to menopause. Her career in the pharmaceutical industry has spanned more than three decades, during which she has launched pharmaceutical brands worldwide and expanded indications for female healthcare brands in multiple countries. She is a published author, TEDx and keynote speaker, executive coach and staunch advocate for innovation in women’s healthcare. During her 10-year tenure as Chief Executive Officer, President and Executive Director of Evofem Biosciences, Inc. (OTCPK: EVFM), Ms. Pelletier has led the company through its transition to the public market, the approval of PHEXXI, the first and only hormone-free, on-demand prescription contraceptive vaginal gel, the acquisition of SOLOSEC, an FDA-approved single-dose oral antimicrobial agent for the treatment of two common sexual health infections: trichomoniasis and bacterial vaginosis, and four consecutive years of net sales growth. Prior to Evofem, Ms. Pelletier was Founder and CEO of Woman Care Global, launching a sustainable supply chain providing access to reproductive healthcare in over 100 low- and middle-income countries. She started her career at G.D. Searle where during her eight-year tenure she served in increasingly senior positions and ultimately as Global Franchise Leader. She is a Director of Windtree Therapeutics, Inc. (Nasdaq: WINT), and IMAC Holdings, Inc. (Nasdaq: BACK). She also serves as an Advisory Board Member for several San Diego non-profit organizations including CEOs Against Cancer, Girls Inc., and The Center for Community Solutions.